OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00000958

China Baoan Group Co Ltd

Specialty ChemicalsVerified

China Baoan Group Co Ltd has a debt-to-equity ratio of 2.19, indicating a capital structure that is significantly leveraged, with total liabilities exceeding total equity by a wide margin. The company's liquidity position is characterized as medium risk, with a current ratio of 1.98, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess liquidity. Free cash flow is negative at -326.52 million CNY, and capital expenditures are substantial at -2.48 billion CNY, indicating ongoing investment in the business. Profitability metrics show a return on equity (ROE) of 2.03% and a return on assets (ROA) of 0.36%, both of which are below the typical thresholds for strong performance in the specialty chemicals industry. The company's operating income of 1.69 billion CNY and net income of 203.04 million CNY suggest modest profitability, with a gross profit margin of 24.65% (calculated from gross profit of 5.68 billion CNY on revenue of 23.04 billion CNY). These figures are below the median for the industry, indicating that the company is underperforming in terms of profitability relative to its peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes, which could impact its revenue stability. The absence of segment-specific revenue data limits the ability to assess the performance of different parts of the business. Looking ahead, the company's growth trajectory is uncertain, as no specific revenue growth projections are provided in the data. However, the company's capital expenditures suggest a commitment to maintaining or expanding its production capacity, which could support future revenue growth. The company's free cash flow is negative, which may limit its ability to fund growth initiatives without external financing. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key financial flag is the negative net cash position after subtracting total debt, which indicates that the company's cash reserves are insufficient to cover its long-term debt obligations. The company's debt-to-equity ratio of 2.19 suggests a high level of financial leverage, which increases the risk of insolvency in the event of a downturn. The low dilution risk is attributed to the absence of significant dilution sources in the provided data. Recent events and disclosures do not provide specific details on the company's recent financial filings or earnings call transcripts. The company's ESG profile includes a Social pillar score of 4.61 (0-100), a Governance pillar score of 26.22 (0-100), and an ESG controversies score of 100.00 (0-100, higher = fewer controversies). These scores suggest that the company has a relatively low level of social responsibility and governance performance, but has not been involved in significant ESG controversies.

30-day price · 000009-0.89 (-10.1%)
Low$7.87High$9.32Close$7.92As of15 May, 00:00 UTC
Profile
CompanyChina Baoan Group Co Ltd
Ticker000009.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. China Baoan Group Co Ltd operates in the specialty chemicals industry, producing and selling a range of chemical products, and generates revenue primarily through the sale of these products to industrial and commercial customers.

Classification. China Baoan Group Co Ltd is classified under the Basic Materials economic sector, within the Chemicals business sector and the Specialty Chemicals industry, with a classification confidence of 0.92.

China Baoan Group Co Ltd has a debt-to-equity ratio of 2.19, indicating a capital structure that is significantly leveraged, with total liabilities exceeding total equity by a wide margin. The company's liquidity position is characterized as medium risk, with a current ratio of 1.98, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess liquidity. Free cash flow is negative at -326.52 million CNY, and capital expenditures are substantial at -2.48 billion CNY, indicating ongoing investment in the business. Profitability metrics show a return on equity (ROE) of 2.03% and a return on assets (ROA) of 0.36%, both of which are below the typical thresholds for strong performance in the specialty chemicals industry. The company's operating income of 1.69 billion CNY and net income of 203.04 million CNY suggest modest profitability, with a gross profit margin of 24.65% (calculated from gross profit of 5.68 billion CNY on revenue of 23.04 billion CNY). These figures are below the median for the industry, indicating that the company is underperforming in terms of profitability relative to its peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes, which could impact its revenue stability. The absence of segment-specific revenue data limits the ability to assess the performance of different parts of the business. Looking ahead, the company's growth trajectory is uncertain, as no specific revenue growth projections are provided in the data. However, the company's capital expenditures suggest a commitment to maintaining or expanding its production capacity, which could support future revenue growth. The company's free cash flow is negative, which may limit its ability to fund growth initiatives without external financing. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key financial flag is the negative net cash position after subtracting total debt, which indicates that the company's cash reserves are insufficient to cover its long-term debt obligations. The company's debt-to-equity ratio of 2.19 suggests a high level of financial leverage, which increases the risk of insolvency in the event of a downturn. The low dilution risk is attributed to the absence of significant dilution sources in the provided data. Recent events and disclosures do not provide specific details on the company's recent financial filings or earnings call transcripts. The company's ESG profile includes a Social pillar score of 4.61 (0-100), a Governance pillar score of 26.22 (0-100), and an ESG controversies score of 100.00 (0-100, higher = fewer controversies). These scores suggest that the company has a relatively low level of social responsibility and governance performance, but has not been involved in significant ESG controversies.
Key takeaways
  • China Baoan Group Co Ltd has a high debt-to-equity ratio of 2.19, indicating a capital structure that is significantly leveraged.
  • The company's profitability metrics, including a return on equity of 2.03% and a return on assets of 0.36%, are below the typical thresholds for strong performance in the specialty chemicals industry.
  • The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, increasing its exposure to regional economic fluctuations.
  • The company's free cash flow is negative at -326.52 million CNY, and capital expenditures are substantial at -2.48 billion CNY, indicating ongoing investment in the business.
  • The company's risk profile is characterized by a medium liquidity risk and a low dilution risk, with a key financial flag being the negative net cash position after subtracting total debt.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$23.04B
Gross profit$5.68B
Operating income$1.69B
Net income$203.0M
R&D
SG&A
D&A
SBC
Operating cash flow$1.16B
CapEx-$2.48B
Free cash flow-$326.5M
Total assets$56.86B
Total liabilities$46.85B
Total equity$10.01B
Cash & equivalents
Long-term debt$21.95B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$23.04B$1.69B$203.0M-$326.5M
FY-1$20.23B$1.41B$172.6M-$2.42B
FY-2$30.71B$2.21B$756.5M-$989.0M
FY-3$32.03B$2.86B$1.16B-$1.20B
FY-4$17.61B$2.14B$1.04B-$271.9M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$56.86B$10.01B
FY-1$53.77B$9.91B
FY-2$50.10B$9.93B
FY-3$52.39B$9.14B
FY-4$37.07B$8.00B
PeriodOCFCapExFCFSBC
FY0$1.16B-$2.48B-$326.5M
FY-1$1.66B-$3.93B-$2.42B
FY-2$5.96B-$2.89B-$989.0M
FY-3$290.5M-$3.69B-$1.20B
FY-4-$279.3M-$2.01B-$271.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$5.82B$17.5M
FQ-1$6.22B$95.6M-$80.2M
FQ-2$5.97B$560.9M$39.4M
FQ-3$5.98B$516.3M$75.2M
FQ-4$4.86B$522.9M$168.6M
FQ-5$5.59B$229.5M-$212.8M
FQ-6$4.61B$397.8M$189.6M
FQ-7$5.03B$437.6M$125.0M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$10.03B$5.21B
FQ-1$56.86B$10.01B
FQ-2$56.58B$10.08B$6.32B
FQ-3$56.05B$10.04B
FQ-4$55.23B$10.11B$6.69B
FQ-5$53.77B$9.91B
FQ-6$52.54B$10.15B$8.12B
FQ-7$51.58B$9.98B
PeriodOCFCapExFCFSBC
FQ0-$199.9M-$836.4M
FQ-1$1.16B-$2.48B
FQ-2$249.7M-$1.55B
FQ-3$18.4M-$1.25B
FQ-4-$507.2M-$870.4M
FQ-5$1.66B-$3.93B
FQ-6$559.4M-$2.66B
FQ-7$268.6M-$2.11B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$10.01B
Net cash-$21.95B
Current ratio2.0
Debt/Equity2.2
ROA0.4%
ROE2.0%
Cash conversion5.7%
CapEx/Revenue-10.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000009Activity
Op margin7.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin0.9%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin24.7%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-10.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity219.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Social pillar4.61 (0-100)
Governance pillar26.22 (0-100)
ESG controversies score100.00 (0-100, higher = fewer controversies)
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 02:17 UTCJob: 1adda507